For Patients

Informed consent: a conversation before a decision

What informed consent means, what to look for in a study discussion, and how to ask for clear answers before deciding about research.

Participant asking a physician a question during an informed consent discussion.

Informed consent is a process for understanding a research study and deciding whether to take part. It includes a discussion and usually a written consent document. Signing a form does not replace the opportunity to ask questions or make a voluntary choice.

The study team should explain the study in terms you can understand. You can ask for more time, clarification, or appropriate language support. This guide helps you prepare for that conversation; the study's own documents and staff must answer questions about its specific requirements.

Start with the research question

Ask the team to describe what researchers want to learn and why the study is being done. Ask what is experimental and what is usual care. This distinction can be easy to miss when research takes place in a familiar clinic with people you already know.

A study may offer an opportunity to contribute to knowledge. It does not promise that an investigational treatment will work for you, and participation can involve risks and inconvenience.

Walk through what will happen

Request a plain-language description of the study from screening to the last planned follow-up. Ask about tests, procedures, visits, treatments, questionnaires, home activities, and any information or samples collected.

If the study assigns participants to groups by chance, ask what each group receives. If some information is masked, ask who knows the assignment and how the team handles medical situations where knowing it is necessary.

You do not need to memorize every detail. It helps to identify the decisions and commitments that matter most to your daily life and health.

Discuss risks in your own words

Ask the team to distinguish common risks, serious risks, and uncertainties. Ask what symptoms or problems you should report and how to reach someone when the office is closed.

You might say: “I understand that this test can cause discomfort. What other risks should I know about, and what would you do if they occur?” This keeps the discussion concrete without requiring medical vocabulary.

Discuss alternatives to participating with the study team and your usual clinician. Research participation should be considered alongside other available options, not presented as a guaranteed route to improvement.

Ask about costs, privacy, and samples

Clarify what the study covers and what might remain your responsibility. Ask about payment or reimbursement terms, including timing and what happens if you do not complete every visit.

For information and samples, ask who may use them, whether future research is involved, whether any choices are optional, and what happens if you withdraw. Do not assume that stopping participation means all previously collected information can be erased.

If a paragraph is difficult to understand, point to it and ask for an explanation. The consent discussion should help you understand the document, not simply direct you back to it.

Understand your ongoing choice

Taking part is voluntary. Ask how to tell the team if you choose to stop and which follow-up steps they recommend for safety. The team may also explain circumstances in which your participation could be ended by the investigator or sponsor.

Consent is relevant throughout the study. If new information is provided, ask how it changes the risks, commitments, or choices you face. You can raise questions after the first consent conversation.

Leave with a usable plan

Keep a copy of the information provided through the study's process, the routine and urgent contact details, and a list of unanswered questions. If you wish, involve a trusted person in the discussion.

Before deciding, try summarizing the study in a few sentences: what it is testing, what you would do, the main risks and uncertainties, and your other options. If part of that summary is unclear, ask again. The question builder can help you organize a follow-up discussion without collecting your health history.

Sources & further reading

  1. FDA: Informed Consent guidance
  2. FDA: Clinical Trial Participation
  3. NIH: Clinical research basics
About this guidance

Educational information, not medical advice or a study-specific compliance determination. This article is not represented as independently clinically reviewed. Images are editorial illustrations.

KEEP YOUR PERSPECTIVE GROWING

Continue reading.